Company Overview of Novo A/S
Novo A/S is a private equity and venture capital arm of The Novo Nordisk Foundation specializing in direct and secondary direct investments. Within direct, it seeks to make private equity and venture capital investments in development stage companies in the form of seed, start up, early venture, mid venture, late venture, growth equity, mature, later stage, and mezzanine investments. It also provides pre-seed grants for early stage projects. The firm seeks to invest in biotechnology, healthcare, and life sciences companies with a focus on investments in products for diagnosis, control, treatment, and prevention of disease; development and application of biotechnology; instruments and medical...
Tuborg Havnevej 19
Founded in 1999
Key Executives for Novo A/S
Compensation as of Fiscal Year 2014.
Novo A/S Key Developments
Novo Ventures Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM
Jan 28 15
Novo Ventures Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Heath Lukatch.
Novo A/S Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM
Oct 31 14
Novo A/S Presents at BIO-Europe 2014, Nov-03-2014 09:00 AM. Venue: Portalhaus Messe Frankfurt, Strasse der Nationen, 60327 Frankfurt, Germany. Speakers: Jack B. Nielsen, Partner.
Novo A/S Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 through Oct-01-2014
Jul 31 14
Novo A/S Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 through Oct-01-2014. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland. Presentation Date & Speakers: Oct-01-2014, Søren Møller. Sep-30-2014, Michael Shalmi, Senior Partner.
Similar Private Companies By Industry
Recent Private Companies Transactions